Stock EVTCY EVOTEC SE
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Evotec SE Other OTC

Equities

EVTCY

US30050E1055

Real-time Estimate Cboe BZX
Other stock markets
 12:04:16 2024-06-18 pm EDT 		5-day change 1st Jan Change
4.085 USD -94.47% Intraday chart for Evotec SE 0.00% 0.00%
Jun. 17 Evotec on the decline - expert fears further profit warning DP
Jun. 12 Evotec benefits modestly from research payment DP

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evotec on the decline - expert fears further profit warning
DP
Evotec benefits modestly from research payment
DP
Evotec to Receive $20 Million Under Neuroscience Partnership with Bristol Myers Squibb
MT
Evotec Gets $20 Million Milestone Payment in Neurodegenerative Disease Collaboration With Bristol Myers Squibb
MT
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
CI
Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb
EQ
Evotec : Presence and Voting Results AGM 2024 229.115 KB
PU
Evotec SE: Results of the Annual General Meeting 2024
EQ
EVOTEC : RBC remains its Buy rating
ZD
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec : Aurobac Therapeutics presents its R&D strategy & pipeline and announces new development program with Boehringer Ingelheim
PU
Evotec : and QIAGEN enter software collaboration for enhanced multi-omics data insights
PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec Partners With French Institutions, Company to Research Obesity
MT
Evotec Joins Collaboration to Identify New Therapies for Obesity, Metabolic Diseases
MT
Evotec, Inserm, Lille Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
CI
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
EQ
Evotec : Update of the Declaration of Conformity with the German Corporate Governance Code for the Year 2023 (May 2024) 127.622 KB
PU
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington's disease
AQ
Evotec Extends Drug Discovery Collaboration With CHDI Foundation for Huntington's Disease
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVT Stock
  4. EVTCY Stock
  5. News Evotec SE